Indeed, our laboratory has found upregulated expression of DRP1 in both PAH and cancer cells with a parallel decrease in the expression of MFN2 in both PAH PASMC (Marsboom et al., 2012a) and lung cancers (Rehman et al., 2012). This evidence concerns the gene MFN2 and lung carcinoma.